Chemotherapy and Surgery in Colon Cancer: for Better Treatment Outcomes

  • 24k

    Total downloads

  • 102k

    Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 08 Mar 2021

Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)

  • Keigo Chida
  • Daisuke Kotani
  • Toshikazu Moriwaki
  • Shota Fukuoka
  • Toshiki Masuishi
  • Atsuo Takashima
  • Yosuke Kumekawa
  • Takeshi Kajiwara
  • Kentaro Yamazaki
  • 18 more
  • Yasuhiro Shimada
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
doi 10.3389/fonc.2021.576036
  • 3,402 views
  • 5 citations